• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[使用Ru106施源器进行脉络膜黑色素瘤近距离治疗中的运动障碍]

[Motility disorders in brachytherapy of choroid melanomas with Ru106 applicators].

作者信息

Langmann A, Langmann G, Unlücerci C, Haller E

机构信息

Universitäts-Augenklinik Graz.

出版信息

Ophthalmologe. 1995 Feb;92(1):76-8.

PMID:7719082
Abstract

Accurate visualization of the tumor base by diaphanoscopy is essential for optimal placement of a ruthenium plaque. Depending on the localization of the tumor, dissection of one or more of the rectus muscles is necessary during placement of the plaque or during the course of protracted irradiation. Orthoptic investigations were performed to evaluate the cause of motility disorders and to follow up the functional outcome. In 13 patients (out of 30) who underwent ruthenium-106 therapy for uveal melanomas, one or more muscles had to be dissected during placement of the plaque and were reinserted in the same operation or after removal of the applicator. In 4 cases rectus muscles had to be shifted and were replaced after the irradiation. There were 5 patients who developed motility disorders with double vision. All of them were orthophoric within 6 months without surgery.

摘要

透照法准确显示肿瘤基底对于钌板的最佳放置至关重要。根据肿瘤的位置,在放置钌板期间或长期照射过程中,需要对一条或多条直肌进行解剖。进行了视轴矫正检查以评估运动障碍的原因并跟踪功能结果。在30例接受钌 - 106治疗葡萄膜黑色素瘤的患者中,有13例在放置钌板期间必须解剖一条或多条肌肉,并在同一次手术中或取出敷贴器后重新植入。在4例患者中,直肌必须移位,并在照射后进行复位。有5例患者出现了伴有复视的运动障碍。他们所有人在6个月内未经手术即恢复了正视。

相似文献

1
[Motility disorders in brachytherapy of choroid melanomas with Ru106 applicators].[使用Ru106施源器进行脉络膜黑色素瘤近距离治疗中的运动障碍]
Ophthalmologe. 1995 Feb;92(1):76-8.
2
Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).钌近距离放射治疗脉络膜和睫状体黑色素瘤的长期生存、解剖学及功能结果(15年β射线治疗经验)
Am J Ophthalmol. 2004 May;137(5):893-900. doi: 10.1016/j.ajo.2003.12.032.
3
Pigmented episcleral deposits after brachytherapy of uveal melanoma.葡萄膜黑色素瘤近距离放射治疗后的色素性巩膜外层沉积物
Ophthalmology. 2006 May;113(5):865-73. doi: 10.1016/j.ophtha.2005.10.059. Epub 2006 Mar 13.
4
[Criteria for assessing the efficacy of brachytherapy of uveal melanomas, complications of therapy and there prevention].[葡萄膜黑色素瘤近距离放射治疗疗效评估标准、治疗并发症及其预防]
Vestn Oftalmol. 1997 May-Jun;113(3):14-6.
5
[Therapy of radiation resistant malignant uveal melanoma with endoresection by pars plana vitrectomy in two patients].[两例采用经扁平部玻璃体切除术进行内切除治疗放射性耐药性恶性葡萄膜黑色素瘤]
Klin Monbl Augenheilkd. 2001 Dec;218(12):800-4. doi: 10.1055/s-2001-19691.
6
[Long-term results of cobalt 60 curietherapy for uveal melanoma].[钴60敷贴治疗葡萄膜黑色素瘤的长期疗效]
J Fr Ophtalmol. 1998 May;21(5):333-44.
7
[Evaluation of 100 melanomas of the choroid and ciliary body treated by application of ruthenium (RU 106 Rh 106)].[应用钌(RU 106 Rh 106)治疗100例脉络膜和睫状体黑色素瘤的评估]
Bull Soc Ophtalmol Fr. 1989 May;89(5):679-82.
8
[Radiation optic neuropathy after the brachytherapy of the uveal melanoma].[葡萄膜黑色素瘤近距离放射治疗后的放射性视神经病变]
Klin Oczna. 2006;108(7-9):278-80.
9
[Plexiglass replicas for optimizing selection and site of ruthenium 106 applicators].用于优化钌106敷贴器选择和放置部位的有机玻璃模型
Klin Monbl Augenheilkd. 1990 Jan;196(1):40-2. doi: 10.1055/s-2008-1046127.
10
Ruthenium applicators in the treatment of choroidal melanomas.钌敷贴器在脉络膜黑色素瘤治疗中的应用
Bull Soc Belge Ophtalmol. 1987;224:51-8.

引用本文的文献

1
Radiotherapy in Uveal Melanoma: A Review of Ocular Complications.眼葡萄膜黑色素瘤的放射治疗:眼部并发症综述。
Curr Oncol. 2023 Jul 3;30(7):6374-6396. doi: 10.3390/curroncol30070470.
2
Long-Term Outcomes in Uveal Melanoma After Ruthenium-106 Brachytherapy.钌-106近距离放射治疗后葡萄膜黑色素瘤的长期预后
Front Oncol. 2022 Jan 3;11:754108. doi: 10.3389/fonc.2021.754108. eCollection 2021.
3
Radiobiological doses, tumor, and treatment features influence on outcomes after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: part II.
放射生物学剂量、肿瘤及治疗特征对巩膜外近距离放射治疗后结局的影响。来自单一机构的20年回顾性分析:第二部分。
J Contemp Brachytherapy. 2018 Aug;10(4):347-359. doi: 10.5114/jcb.2018.77955. Epub 2018 Aug 31.